11/27
06:18 am
fbrx
Forte Biosciences (NASDAQ:FBRX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Forte Biosciences (NASDAQ:FBRX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
11/27
06:18 am
fbrx
Forte Biosciences (NASDAQ:FBRX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Forte Biosciences (NASDAQ:FBRX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
11/25
07:55 am
fbrx
Rating for FBRX
Low
Report
Rating for FBRX
11/25
07:19 am
fbrx
Forte Biosciences (NASDAQ:FBRX) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
Low
Report
Forte Biosciences (NASDAQ:FBRX) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
11/25
07:19 am
fbrx
Forte Biosciences (NASDAQ:FBRX) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
Low
Report
Forte Biosciences (NASDAQ:FBRX) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
11/25
06:34 am
fbrx
Forte Biosciences initiated with an Outperform at Evercore ISI
Medium
Report
Forte Biosciences initiated with an Outperform at Evercore ISI
11/25
06:34 am
fbrx
Forte Biosciences initiated with an Outperform at Evercore ISI
Medium
Report
Forte Biosciences initiated with an Outperform at Evercore ISI
11/17
08:06 am
fbrx
Forte Biosciences (NASDAQ:FBRX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $61.00 price target on the stock.
Low
Report
Forte Biosciences (NASDAQ:FBRX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $61.00 price target on the stock.
11/17
07:49 am
fbrx
Rating for FBRX
Low
Report
Rating for FBRX